Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir (Q44501340)
Jump to navigation
Jump to search
scientific article published in December 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir |
scientific article published in December 1999 |
Statements
1 reference
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir (English)
1 reference
1 reference
Lori F
1 reference
Jessen H
1 reference
Lieberman J
1 reference
Finzi D
1 reference
Rosenberg E
1 reference
Walker B
1 reference
Siliciano RF
1 reference
Lisziewicz J
1 reference
1 December 1999
1 reference
1 reference
180
1 reference
6
1 reference
1827-1832
1 reference
Identifiers
1 reference
1 reference